Concepedia

Vivienne Marsh

VM

Statistics

Publications

6

Citations

850

H-Index

6

Active since

2001

Affiliations

Array BioPharma (United States)(Current)

Vivienne Marsh is an author at Array BioPharma (United States) specializing in pharmacology, mek inhibitors, and oncogenic signaling pathways.

Publications per year

2001–2010

6

Publications

6

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Tammie C. Yeh, Vivienne Marsh, Bryan A. Bernat et al. · Clinical Cancer Research · 2007 · 583 citations · Full text

, , +14

Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors

C. Todd Eary, Zachary S. Jones, Robert D. Groneberg et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 87 citations · Full text

, , +7

Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach

Roger A. Smith, J A Barbosa, Cheri L. Blum et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 85 citations · Full text

, , +17

Potent and Selective Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1- methylpyridin-2(1<i>H</i>)-ones

Eli M. Wallace, Joseph P. Lyssikatos, James F. Blake et al. · Journal of Medicinal Chemistry · 2005 · 40 citations · Full text

, , +13

Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor

Patrice A. Lee, Eli Wallace, Allison Marlow et al. · Cancer Research · 2010 · 37 citations

, , +17

1–5 of 6